Effect of intravenous infusion of proglumide on ruminal motility in conscious sheep (Ovis aries).
The effects of intravenous infusion of proglumide on regular ruminal contractions were examined in conscious sheep using doses that inhibit pancreatic exocrine secretion. After a control period of 20 min, proglumide was infused intravenously for 40 min at a dose of 15, 30 or 60 micromol/kg per min and venous blood was collected. The intravenous infusion of proglumide significantly increased the frequency of ruminal contractions at 15 micromol/kg per min without altering the amplitude, while it significantly decreased the frequency and amplitude of ruminal contractions at 30 and 60 micromol/kg per min in a dose-dependent manner. Proglumide did not increase contractile activity of the omasum, abomasum and duodenum or the plasma concentration of immunoreactive cholecystokinin (CCK). Application of proglumide at 1-30 mmol/L inhibited bethanechol-induced contraction in both longitudinal and circular muscle strips of the dorsal sac of the rumen. These results suggest that proglumide at a low dose acts indirectly on the rumen as a CCK receptor antagonist to increase the frequency of contractions, whereas at higher doses it inhibits cholinergic-induced contraction of the ruminal muscles or acts as an agonist to inhibit contractions in sheep. Hence, proglumide at high doses seems unsuitable for research or therapeutic use as a CCK receptor blockade in sheep.
Onaga
T
T
Laboratory of Veterinary Physiology, Department of Biosciences, School of Veterinary Medicine, Rakuno Gakuen University, Japan. onaga@rakuno.ac.jp
D000018:Abomasum / Q000187:drug effects / Q000502:physiology; D000818:Animals; D002766:Cholecystokinin / Q000097:blood; D004386:Duodenum / Q000187:drug effects / Q000502:physiology; D005769:Gastrointestinal Motility / Q000187:drug effects*; D066298:In Vitro Techniques; D007262:Infusions, Intravenous / Q000662:veterinary; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009851:Omasum / Q000187:drug effects / Q000502:physiology; D011377:Proglumide / Q000008:administration & dosage / Q000494:pharmacology*; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors; D012417:Rumen / Q000187:drug effects* / Q000502:physiology; D012756:Sheep / Q000502:physiology*; D014160:Transducers, Pressure / Q000662:veterinary
D011949:Receptors, Cholecystokinin; D002766:Cholecystokinin; D011377:Proglumide